Mechanisms of central and peripehral T-cell tolerance: lessons from experimental models of multiple sclerosis

被引:41
作者
Anderton, S [1 ]
Burkhart, C [1 ]
Metzler, B [1 ]
Wraith, D [1 ]
机构
[1] Univ Bristol, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
基金
英国惠康基金;
关键词
D O I
10.1111/j.1600-065X.1999.tb01311.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies of experimental autoimmune encephalomyelitis in conventional and transgenic mouse models have clarified mechanisms of central and peripheral tolerance to myelin antigens. It is now clear that myelin antigens are expressed in the thymus and their expression can influence generation of the potential autoimmune T-cell repertoire. How autoreactive T cells escape tolerance in the thymus is largely unclear. One mechanism has been revealed through the use of a transgenic mouse expressing a T-cell receptor specific for a myelin antigen. T cells specific for the N-terminal epitope of myelin basic protein escape tolerance through low avidity interaction. The affinity of antigen binding to MHC also proves to be important for induction of peripheral tolerance. Peptides may be administered in solution to adults in order to reinstate peripheral tolerance and suppress disease. Induction of antigen-specific suppression with synthetic peptides can result in either Linked or bystander suppression and this appears to involve the generation of T cells secreting suppressive cytokines. The use of altered peptide ligands for induction of peripheral tolerance has been investigated. This can be achieved but the complexity of the approach argues against its use for treatment of human autoimmune diseases.
引用
收藏
页码:123 / 137
页数:15
相关论文
共 80 条
  • [1] LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION
    ACHAORBEA, H
    MITCHELL, DJ
    TIMMERMANN, L
    WRAITH, DC
    TAUSCH, GS
    WALDOR, MK
    ZAMVIL, SS
    MCDEVITT, HO
    STEINMAN, L
    [J]. CELL, 1988, 54 (02) : 263 - 273
  • [2] Role of interleukin 10 in specific immunotherapy
    Akdis, CA
    Blesken, T
    Akdis, M
    Wüthrich, B
    Blaser, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 98 - 106
  • [3] T-cell-receptor affinity and thymocyte positive selection
    Alam, SM
    Travers, PJ
    Wung, JL
    Nasholds, W
    Redpath, S
    Jameson, SC
    Gascoigne, NRJ
    [J]. NATURE, 1996, 381 (6583) : 616 - 620
  • [4] Anderton SM, 1998, J IMMUNOL, V161, P3357
  • [5] Anderton SM, 1998, EUR J IMMUNOL, V28, P1251, DOI 10.1002/(SICI)1521-4141(199804)28:04<1251::AID-IMMU1251>3.0.CO
  • [6] 2-O
  • [7] Anderton SM, 1999, EUR J IMMUNOL, V29, P1850, DOI 10.1002/(SICI)1521-4141(199906)29:06<1850::AID-IMMU1850>3.0.CO
  • [8] 2-N
  • [9] Anderton SM, 1998, CIBA F SYMP, V215, P120
  • [10] Bluestone JA, 1997, J IMMUNOL, V158, P1989